Skip to main content

A guide to vaccinations for COVID-19: references

Reference list for 'A guide to vaccinations for COVID-19'

  1. University of Oxford, Vaccine Knowledge Project Herd immunity (updated: September 2023)
  2. UK Health Security Agency 2023 Greenbook chapter 14a COVID-19 (published 4 September 2023) 
  3. UK Health Security Agency 2023 Guide to the use of human and animal products in vaccines (updated 13 March 2023)
  4. UK Health Security Agency 2022 The effectiveness of vaccination against long COVID (published 12 January 2022)
  5. University of Oxford, Vaccine Knowledge Project How vaccines are tested, licensed and monitored (updated 17 August 2023)
  6. Victoria Male 2021 Are COVID-19 vaccines safe in pregnancy? Nature Reviews Immunology DOI: 10.1038/s41577-021-00525-y
  7. Zace et al. 2022 The impact of COVID-19 vaccines on fertility – A systematic review and meta-analysis Vaccine DOI: 10.1016/j.vaccine.2022.09.019
  8. Victoria Male Explainer on COVID vaccination, fertility, pregnancy and breastfeeding (updated 3 October 2023)
  9. Pardi et al. 2018 mRNA vaccines – a new era in vaccinology Nature Reviews Drug Discovery DOI 10.1038/nrd.2017.243
  10. Polack et al. 2020 Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine New England Journal of Medicine DOI: 10.1056/NEJMoa2034577
  11. UK Health Security Agency 2022 How well do vaccines protect against Omicron? What the data shows (published 10 February 2022)
  12. NHS 2022 Pregnancy, breastfeeding, fertility and COVID-19 vaccination (updated 24 October 2022)
  13. Allotey et al. 2020 Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis The British Medical Journal DOI: 10.1136/bmj.m3320
  14. Baden et al. 2020 Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine New England Journal of Medicine DOI: 10.1056/NEJMoa2035389
  15. Medicines & Healthcare products Regulatory Agency 2023 Product Information Leaflet (PIL) for VidPrevtyn Beta dispersion for injection (updated 20 April 2023)
  16. UK Health Security Agency 2023 Guide to the use of human and animal products in vaccines (updated 13 March 2023)
  17. De Bruyn et al. 2023 Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study eClinical Medicine DOI: 10.1016/j.eclinm.2023.102109
  18. Kirsebom et al. 2023 Effectiveness of the adjuvanted Sanofi/GSK (VidPrevtyn Beta) and Pfizer-BioNTech (Comirnaty Original/Omicron BA.4-5) bivalent vaccines against hospitalisation amongst adults aged 75 years and older in England, estimated using a test-negative case control study design preprint medRxiv DOI: 10.1101/2023.09.28.23296290
  19. Novavax Our Matrix-M™ adjuvant technology (accessed 23 October 2023)
  20. Sharma et al. 2023 Saponins: A concise review on food related aspects, applications and health implications Food Chemistry Advances DOI: 10.1016/j.focha.2023.100191
  21. Heath et al. 2021 Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine New England Journal of Medicine DOI: 10.1056/nejmoa2107659
  22. Johnson & Johnson 2020 Johnson & Johnson announces European Commission approval for Janssen’s preventive Ebola vaccine (accessed 23 October 2023)
  23. University of Oxford, Oxford Vaccine Group Vaccines against Ebola virus disease (published 19 June 2019) 
  24. Voysey et al. 2021 Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK The Lancet DOI: 10.1016/S0140-6736(20)32661-1